Rinda Sama - 08 Jun 2021 Form 4 Insider Report for Axonics, Inc.

Role: Chief Operating Officer
Signature: /s/ Dan Dearen, as Attorney-in-Fact for Rinda Sama
Issuer symbol: N/A
Transactions as of: 08 Jun 2021
Net transactions value: -$108,464
Form type: 4
Filing time: 10 Jun 2021, 21:38:03 UTC
Previous filing: 13 May 2021
Next filing: 16 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXNX	Common Stock	Options Exercise	$14,190	+1,000	+3.5%	$14.19^*	29,898	08 Jun 2021	Direct
transaction	AXNX	Common Stock	Sale	$60,234	-1,000	-3.3%	$60.23	28,898	08 Jun 2021	Direct	F1, F2
transaction	AXNX	Common Stock	Options Exercise	$19,327	+1,362	+4.7%	$14.19^*	30,260	10 Jun 2021	Direct
transaction	AXNX	Common Stock	Sale	$81,747	-1,362	-4.5%	$60.02	28,898	10 Jun 2021	Direct	F1, F3
holding	AXNX	Common Stock						4,000	08 Jun 2021	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXNX	Stock Option (Right to Buy)	Options Exercise	$0	-1,000	-2.4%	$0.000000	40,568	08 Jun 2021	Common Stock	1,000	$14.19	Direct	F4
transaction	AXNX	Stock Option (Right to Buy)	Options Exercise	$0	-1,362	-3.4%	$0.000000	39,206	10 Jun 2021	Common Stock	1,362	$14.19	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2	This transaction was executed in multiple trades at prices ranging from $60.20 to $60.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $60.00 to $60.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 30th, 2020, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 30th, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.